Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.
Open Access
- 1 September 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 135 (3) , 2015-2019
- https://doi.org/10.4049/jimmunol.135.3.2015
Abstract
A neoantigen was detected on human C3bi and C3d by using the monoclonal antibody (MoAb) 130. The antibody bound to EC3bi and EC3d cells but not to EC3b. Although highly purified C3bi or C3d strongly inhibited the binding of the antibody to EC3d, highly purified C3c had no such effect. Native C3, C3b, or C3(H2O) inhibited this binding only weakly. The neoantigen was also detected in serum after activation with zymosan or heat-aggregated IgG, and it was found bound to the aggregated IgG and zymosan particles. Plasma samples from patients with immunologic disorders were tested for this neoantigen, and 25 out of 43 samples tested were found to have levels of neoantigen corresponding to 2 to 11.5% complement activation, whereas 13 out of 14 normal donor plasmas contained amounts of neoantigen indicating much less than 1% complement activation.This publication has 17 references indexed in Scilit:
- Evidence for presence of an internal thiolester bond in third component of human complement.Proceedings of the National Academy of Sciences, 1980
- Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.The Journal of Experimental Medicine, 1980
- Detection and partial characterization of circulating immune complexes with solid-phase anti-C3.The Journal of Immunology, 1980
- 3 RAT MONOCLONAL-ANTIBODIES TO HUMAN C-31980
- Mechanism of action of factor D of the alternative complement pathway.The Journal of Experimental Medicine, 1978
- Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cellsProceedings of the National Academy of Sciences, 1978
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.Journal of Clinical Investigation, 1977
- Third component of human complement: purification from plasma and physicochemical characterizationBiochemistry, 1976
- A SEDIMENTATION PATTERN TECHNIQUE FOR MEASURING CONGLUTINATION - ITS APPLICATION TO DEMONSTRATING IMMUNOCONGLUTININS TO C'41966